Publicacións (469) Publicacións nas que participase algún/ha investigador/a

filter_list Internal Medicine

2025

  1. A Contemporary Picture of Coagulase-Negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort Study

    Journal of the American College of Cardiology, Vol. 85, Núm. 4, pp. 305-318

  2. Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score

    European heart journal, Vol. 46, Núm. 3, pp. 273-284

  3. Inflammatory Mediators in Pericardial Fluid in Patients Undergoing Cardiac Surgery

    CJC Open, Vol. 7, Núm. 2, pp. 193-202

  4. Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure

    European Journal of Clinical Investigation

  5. The CNIC polypill (Acetylsalicylic acid + Atorvastatin + Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeutic approaches

    International Journal of Cardiology, Vol. 418

2024

  1. Accumulation of Inflammatory Mediators in the Normal Pericardial Fluid

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  2. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

  3. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers

    Journal of Translational Medicine, Vol. 22, Núm. 1

  4. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)

    European Journal of Heart Failure, Vol. 26, Núm. 9, pp. 1999-2007

  5. Compartmentalization of the Inflammatory Response in the Pericardial Cavity in Patients Undergoing Cardiac Surgery

    International Journal of Molecular Sciences, Vol. 25, Núm. 24

  6. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

  7. Effect of age on clinical impact and mid-term denervation in patients undergoing cardioneuroablation

    Scientific Reports, Vol. 14, Núm. 1

  8. Effectiveness of the CNIC polypill in secondary cardiovascular prevention in the subgroup of patients of the NEPTUNO study using atorvastatin doses of 20 mg

    Archivos de Cardiologia de Mexico, Vol. 94, Núm. 4, pp. 429-443

  9. Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation

    Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23

  10. Manual de procedementos en pacientes críticos cardiovasculares

    Conselleria de Sanidade

  11. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

  12. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  13. Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry

    Revista Espanola de Cardiologia

  14. The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease

    European Heart Journal Open, Vol. 4, Núm. 2

  15. The Role of Natriuretic Peptides in Pericardial Fluid in Predicting Cardiovascular Disorders: A Systematic Review

    Cardiology in Review